To aid in the design of natural history studies and identification of clinical trial endpoints, a draft disease concept map of SLC6A1-NDD was created based on a survey of the literature, an analysis of social media interactions, and interviews with two key opinion leaders (KOLs). This evidence concerns the gene SLC6A1 and Neurodevelopmental delay.